Principal Financial Group Inc Maravai Lifesciences Holdings, Inc. Transaction History

Principal Financial Group Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$6.84 - $9.73 $2.14 Million - $3.05 Million	-313,587 Reduced 47.07%	352,600 $2.93 Million
Q2 2024 Jul 29, 2024	BUY	$6.87 - $11.34 $1.76 Million - $2.9 Million	255,990 Added 62.41%	666,187 $4.77 Million
Q1 2024 Apr 29, 2024	BUY	$5.11 - $8.76 $2.04 Million - $3.49 Million	398,306 Added 3349.64%	410,197 $3.56 Million
Q3 2023 Nov 02, 2023	BUY	$9.14 - $12.85 $7,284 - $10,241	797 Added 7.18%	11,891 $118,000
Q2 2023 Aug 07, 2023	SELL	$12.09 - $15.0 $7,846 - $9,735	-649 Reduced 5.53%	11,094 $137,000
Q1 2023 May 09, 2023	SELL	$12.99 - $16.48 $28,655 - $36,354	-2,206 Reduced 15.81%	11,743 $164,000
Q4 2022 Feb 09, 2023	SELL	$12.5 - $24.78 $502,400 - $995,957	-40,192 Reduced 74.24%	13,949 $199,000
Q3 2022 Nov 09, 2022	SELL	$20.6 - $30.37 $12.1 Million - $17.8 Million	-587,208 Reduced 91.56%	54,141 $1.38 Million
Q2 2022 Aug 10, 2022	BUY	$26.05 - $37.48 $3.64 Million - $5.23 Million	139,667 Added 27.84%	641,349 $18.2 Million
Q1 2022 May 09, 2022	SELL	$24.46 - $40.92 $1.69 Million - $2.82 Million	-69,025 Reduced 12.09%	501,682 $17.7 Million
Q4 2021 Feb 09, 2022	SELL	$35.0 - $45.94 $1.56 Million - $2.05 Million	-44,634 Reduced 7.25%	570,707 $23.9 Million
Q3 2021 Nov 09, 2021	BUY	$36.8 - $60.62 $4.5 Million - $7.42 Million	122,409 Added 24.83%	615,341 $30.2 Million
Q2 2021 Aug 10, 2021	BUY	$32.46 - $45.0 $15.8 Million - $21.9 Million	486,275 Added 7304.72%	492,932 $20.6 Million
Q1 2021 May 10, 2021	BUY	$25.8 - $38.49 $171,750 - $256,227	6,657 New	6,657 $237,000

234

140M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $738M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.